在健康的老年人中补充维生素E和体内免疫反应. 一个随机对照试验
S N Meydani1, M Meydani, J B Blumberg
1Nutritional Immunology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA. SvMeydanivIM@HNRC.TUFTS.EDU
JAMA
|May 7, 1997
概括
维生素E补充剂改善了健康老年人的细胞介导免疫力. 每天200毫克的剂量显著提高了免疫反应,没有出现不良影响,并表明更高的维生素E水平有利于老年人的免疫功能.
科学领域:
- 免疫学 免疫学 免疫学
- 老年学是指老年学的学科.
- 营养科学 营养科学
背景情况:
- 衰老与细胞介导免疫力下降有关.
- 维生素E是一种抗氧化剂,具有潜在的免疫调节作用.
- 优化老年人的免疫功能对于健康和疾病预防至关重要.
研究的目的:
- 研究维生素E补充剂对健康老年人细胞介导免疫的体内测量中的长期影响.
- 为了确定免疫增强的最佳剂量.
主要方法:
- 随机,双盲,安慰剂对照试验,包括88名65岁以上的健康受试者.
- 补充维生素E (60,200或800毫克/天) 或安慰剂235天.
- 评估延迟型过敏性 (DTH) 皮肤反应和对疫苗的抗体标位 (乙型肝炎,破伤风,耳,肺炎球菌).
主要成果:
- 维生素E补充剂,特别是每天200毫克,显著改善了DTH反应和对乙型肝炎和破伤风疫苗的抗体标位.
- 较高的血清α-托哥菲罗尔水平与增强的抗体反应和DTH相关.
- 没有观察到对角膜炎抗体标位,免疫球蛋白水平,T/B细胞计数或自身抗体水平的显著影响.
结论:
- 以高于目前推的剂量补充维生素E可以增强健康老年人的T细胞介导免疫功能.
- 每天200毫克的剂量似乎有效改善特定的免疫标记.
- 没有发现任何不良影响,这表明了有利的安全性.
相关概念视频
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


